Previous Article | Next Article 
Molecular and Cellular Biology, January 2000, p. 389-401, Vol. 20, No. 1
0270-7306/0/$04.00+0
DNA Binding Site Selection of Dimeric and
Tetrameric Stat5 Proteins Reveals a Large Repertoire of Divergent
Tetrameric Stat5a Binding Sites
Elisabetta
Soldaini,1,
Susan
John,1
Stefano
Moro,2,
Julie
Bollenbacher,1
Ulrike
Schindler,3 and
Warren
J.
Leonard1,*
Laboratory of Molecular Immunology, National
Heart, Lung, and Blood Institute,1 and
Laboratory of Bioorganic Chemistry, National Institute of
Diabetes and Digestive and Kidney Diseases,2
National Institutes of Health, Bethesda, Maryland 20892, and
Tularik, Inc., South San Francisco, California
940803
Received 8 February 1999/Returned for modification 8 March
1999/Accepted 23 September 1999
 |
ABSTRACT |
We have defined the optimal binding sites for Stat5a and Stat5b
homodimers and found that they share similar core
TTC(T/C)N(G/A)GAA interferon gamma-activated sequence (GAS)
motifs. Stat5a tetramers can bind to tandemly linked GAS motifs, but
the binding site selection revealed that tetrameric binding also can be
seen with a wide range of nonconsensus motifs, which in many cases did
not allow Stat5a binding as a dimer. This indicates a greater degree of flexibility in the DNA sequences that allow binding of Stat5a tetramers
than dimers. Indeed, in an oligonucleotide that could bind both dimers
and tetramers, it was possible to design mutants that affected dimer
binding without affecting tetramer binding. A spacing of 6 bp between
the GAS sites was most frequently selected, demonstrating that this
distance is favorable for Stat5a tetramer binding. These data provide
insights into tetramer formation by Stat5a and indicate that the
repertoire of potential binding sites for this transcription factor is
broader than expected.
 |
INTRODUCTION |
Signal transducers and activators of
transcription (STAT proteins) are latent transcription factors located
in the cytosol of resting cells (8). Following stimulation
with cytokines or growth factors, these proteins are rapidly tyrosine
phosphorylated, allowing them to dimerize and translocate to the
nucleus, where they bind to target genes. To date, seven mammalian STAT
proteins have been identified. While Stat2 is activated by alpha/beta
interferon, Stat4 by interleukin-12 (IL-12), and Stat6 by IL-4-IL-13,
Stat1, Stat3, Stat5a, and Stat5b are activated by a wider range of
stimuli (8, 13, 17).
Human Stat5a and Stat5b proteins are 91% identical at the amino acid
level and are encoded by two closely linked genes located on chromosome
17q11.2 (12, 19, 31). Stat5 proteins can be activated by
multiple cytokines and growth factors including prolactin, growth
hormone, IL-2, IL-7, IL-9, IL-15, IL-3, granulocyte-macrophage colony-stimulating factor, IL-5, erythropoietin, and thrombopoietin (reviewed in reference 17). Stat5a
/
,
Stat5b
/
, and Stat5a
/
Stat5b
/
mice have been generated. Whereas
Stat5a
/
mice have defective mammary gland development
and lactogenesis due to defective prolactin signaling (21),
Stat5b
/
mice exhibit a loss of sexually dimorphic
growth due to defective growth hormone signaling (34). The
analysis of Stat5a
/
Stat5b
/
mice has
shown more severe defects associated with prolactin and growth hormone
(32), as well as defects in fetal erythropoiesis (31a). In the immune system, both Stat5a
/
and Stat5b
/
mice exhibit decreased IL-2-induced
IL-2R
expression (14, 27); however, high doses of IL-2
can overcome defective IL-2-induced proliferation in
Stat5a
/
mice but not in Stat5b
/
mice.
Moreover, Stat5b
/
mice have a greater defect in their
natural killer (NK) cell function (14). Finally, mice
lacking expression of both Stat5a and Stat5b have a greater
immunological defect than seen in either alone, both in terms of T-cell
proliferation and in the development of NK cells (25). Thus,
Stat5a and Stat5b appear to have both overlapping and distinctive functions.
Most STATs bind to GAS (IFN-
-activated sequence) motifs, with a
consensus TTCNmGAA, with
m = 4 for Stat6 and m = 3 for the
optimal binding of other STATs (11, 30, 39). However, differences in the fine DNA binding specificities for the various STAT
proteins were shown to depend on the sequence of nucleotides in the GAS
element as well as of those immediately adjacent to it (reviewed in
reference 9). An added complexity related to STAT
binding properties can occur based on the ability of STATs to bind to
DNA as higher-order complexes occurring through N-terminal interactions
between adjacent dimers (15, 23, 36, 37, 39). Tetramer
formation can stabilize the binding of STAT dimers to two tandem
low-affinity sites by decreasing the off-rate of the complex (15,
36, 37). Moreover, such oligomerization of STAT proteins
has been suggested to contribute to their DNA binding specificity
(39).
Since different STATs activate nonidentical sets of genes, one
mechanism contributing to this selectivity is their differential DNA
binding specificities. Therefore, we determined the optimal binding
sites for Stat5a and Stat5b to evaluate if any binding differences were
found for these highly homologous proteins. In so doing, we have
established the consensus sequences for optimal binding of Stat5a and
Stat5b homodimers and found that they are very similar. We have also
identified sequences that efficiently bound Stat5a tetramers, providing
new insights into the DNA sequence requirements for Stat5a dimer versus
tetramer formation.
 |
MATERIALS AND METHODS |
Expression and purification of recombinant Stat5 proteins.
The production and purification of Stat5a, Stat5b, and Stat5aW37A in
baculovirus-infected insect cells were previously described (15). The Stat5aY694F mutant was generated from the
Stat5a-encoding transfer vector by using the MORPH Site-Specific
Plasmid DNA Mutagenesis Kit (5'-3', Inc.). Immunoblotting was performed
with a pan-Stat5 antibody (Transduction Labs), Stat5a- or
Stat5b-specific antisera (19), or the PY20
antiphosphotyrosine monoclonal antibody mAb (Santa Cruz Biotechnology).
The purity of protein preparations was evaluated by silver staining
(SilverXpress; Novex).
DNA binding site selection.
Optimal Stat5a and Stat5b
binding sites were selected according to the method of Pollock and
Treisman (29) except that the pool of double-stranded
oligonucleotides (R76) had the following sequence:
5'-CAGGTCAGTATAGCGGATCCTGTCGN26GAGGCCACTCGAGTGCA ACTGCAGC-3' (top strand; BamHI and XhoI sites are
underlined; N26 corresponds to nucleotides where all four
bases were randomized). Approximately 300 ng of purified recombinant
Stat5a, Stat5b, and Stat5aY694F were used for binding reactions.
Antisera specific for human Stat5a or Stat5b (19) were used
to immunoprecipitate DNA-protein complexes. A binding site selection
was previously performed for Stat6 (30).
Electrophoretic mobility shift assays (EMSAs).
In some
cases, probes were prepared by PCR labeling of oligonucleotides
containing flanking sequences (using forward primer 5'-TAGTGGATCCTGTGG-3' and reverse primer
5'-CCCTCGAGTGGCCTC-3'); certain mutant oligonucleotides
(e.g., 947M4) contained changes in the 3' flank, and in these cases the
reverse primer was 5'-CCCTCGAGTGGCCGA-3'. Each flanking
primer used for PCR amplification inadvertently contained a single
nucleotide change from the R76 sequence. Two picograms of each relevant
oligonucleotide were amplified in PCR buffer containing 10 mM dGTP,
dATP, and dTTP, 80 µM dCTP, 80 ng of each primer, and Taq
polymerase and labeled with 0.5 µl of [
-32P]dCTP, in
a 20-µl total reaction volume for five cycles of 45 s at 94°C,
45 s at 40°C with the RAMP set to 5.00, and 45 s at 72°C.
This was followed by 25 cycles of 30 s at 94°C, 30 s at 40°C, and 30 s at 72°C. PCR products were run on 8%
polyacrylamide gels, and the bands were excised and purified. In other
cases, oligonucleotides corresponding to both strands were synthesized with XmaI and BglII ends, annealed, end labeled
with [
-32P]dCTP by using Klenow fill-in (New England
Biolabs), and gel purified. Purified Stat5 proteins (150 ng unless
otherwise stated) were incubated on ice with 1.34 µg of poly(dI-dC)
in binding buffer (20 mM Tris-HCl, pH 7.5; 20 mM HEPES, pH 7.9; 400 mM
KCl; 1 mM EDTA; 1 mM dithiothreitol, 1 mM AEBSF; 1 mM
Na3VO4; 10 mM NaF; and 1 µg of bovine serum
albumin per ml) for 15 min before addition of 40,000 cpm (corresponding
to 0.2 to 0.6 ng) of probe. Reaction mixtures (20 µl) were incubated
on ice for another 15 min and then resolved on 6% nondenaturing
polyacrylamide gels (59:1 acrylamide-bisacrylamide).
Methylation interference assays.
Oligonucleotides were
cloned in pGL3 basic (Promega Corp.) between the XmaI and
BglII sites. Plasmids were linearized at either end with
XmaI or BglII and end labeled with
[
-32P]dGTP and [
-32P]dCTP (both
>3,000 Ci/mmol; Amersham) by a fill-in reaction with Klenow enzyme.
Probes were released by a second digestion with XmaI or
BglII, as appropriate, and purified on nondenaturing
polyacrylamide gels. Then, 2 × 106 cpm of probe and
0.6 to 3 µg of Stat5a protein or an equivalent amount of Stat5aW37A
were used in each binding reaction. Methylation interference assays
were performed as described earlier (2).
Molecular modeling of Stat5.
The best alignment between the
amino acid sequences of human Stat5a, Stat5b, and the other five known
STAT proteins was obtained by using the Needleman-Wunsch algorithm
(28) implemented in Look version 3 (Molecular Application
Group, Palo Alto, Calif.). Importantly, Stat1 and Stat5 showed marked
amino acid sequence conservation, with 37% identity in a sequence
alignment and the preservation of a number of residues throughout all
of the STAT protein sequences examined. We therefore built molecular
homology models of Stat5a and Stat5b based on the high-resolution (2.9 Å) structure of Stat1/DNA complex (7; see also
http://www.rockefeller.edu/kuriyan/). An alignment analysis revealed
several regions that markedly differ between Stat5a/Stat5b and Stat1,
such as the segment between
1 and
2 and the
4/
5/
5 region
(see Fig. 1B). However, homology modeling of both Stat5a and Stat5b
could be performed with Segment Match Modeling (SegMod; also
implemented in Look version 3), which uses both the backbone and side
chains of fragments to model a complete system in one step. The average
of 10 independent models was minimized by using the molecular mechanics
program ENCAD (18) until convergence was reached, as judged
by root mean square of the energy gradient (average derivative of <0.1
kcal/mol/Å). The quality of the model was assessed with PROCHECK
(16) by using comparison values typical for a 2.0-Å
resolution X-ray structure. After the homology modeling, DNA-Stat5a and
DNA-Stat5b complexes were assembled. The DNA atomic coordinates
corresponding to the M67 GAS element (5'-TTCCCGTAA-3'),
which was cocrystallized with Stat1, were substituted by the ones
for the Fc
RI GAS element (5'-TTCCCAGAA-3'), since the
latter motif binds Stat5 well, whereas the former does not (data not
shown and reference 3). Double-helical B-form DNA
corresponding to the M67 and Fc
RI sequences were built by using the
Biopolymer Builder implemented in Sybyl 6.4 (TRIPOS Associates, St.
Louis, Mo.).
For building models of two Stat5a dimers bound to DNA, we used B-form
double-helical DNAs corresponding to oligonucleotide 928 (5'-GTTTCGTGGAATCGTGGCACTATGAACCA-3',
which has a spacing of six positions between the GAS motifs
[underlined]) or to a modified version of this oligonucleotide in
which the spacing was increased to 11, 5'-GTTTCGTGGAATCGTagctaGGCACTATGAACCA-3' (lowercase nucleotides are those inserted in the 928 sequence). The protein-DNA complex was modeled by using manual docking procedures (Dock module in Sybyl) and minimized until convergence was achieved, as
judged by the root mean square of the energy gradient (average derivative of <0.1 kcal/mol/Å) by using the AMBER force field (38), implemented in Macromodel 6.0 (24).
 |
RESULTS |
Stat5a and Stat5b have similar optimal DNA binding
preferences.
Human Stat5a and Stat5b differ by six amino acids in
their DNA-binding domains (shown in Fig.
1B), which suggested that they might
differ in their DNA binding specificities. We therefore used a DNA
binding site selection method (29) to investigate this
possibility. Human Stat5a and Stat5b proteins were expressed by using a
baculovirus expression system and purified from insect cells; the
purity of these proteins was evaluated by silver staining (Fig.
2A; for lanes 1 and 2, two concentrations
of protein were loaded). Western blotting with pan-Stat5-, Stat5a-, and
Stat5b-specific antisera confirmed the identities of the proteins (Fig.
2B to D, lanes 1 and 2). These proteins were constitutively
phosphorylated on tyrosine, as shown by Western blotting with PY20
(Fig. 2E, lanes 1 and 2). Stat5a mutants that cannot form tetramers
(W37A) or that are not tyrosine phosphorylated and therefore cannot
dimerize or bind DNA (Y694F) were also prepared; these proteins were
expressed at a lower purity and concentration (Fig. 2A, lanes 3 and 4 versus lane 1), so the amount of these preparations added in
experiments was increased to adjust for the lower purity of Stat5aW37A
and Stat5aY694F proteins. As expected, Stat5aY694F was nonreactive on
PY20 blots (Fig. 2E, lane 3), indicating that this tyrosine residue was
phosphorylated in the wild-type Stat5a protein.

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 1.
Domain structure and sequence alignment of Stat5
proteins. (A) Schematic representation of Stat5 proteins: the domain
boundaries of human Stat5a are shown. The Stat5a core region (residues
141 to 706) used to construct the computer model shown in Fig. 6 is
indicated by the open box. (B) Sequence alignment of the core regions
of human Stat5a and Stat5b. Dots indicate identical nucleotides;
hyphens are gaps introduced to optimize alignment. Amino acids in the
DNA binding domain which differ between Stat5a and Stat5b are
indicated. The loop which intercalates into the major groove of DNA is
in the "DNA binding domain" box. Tyr694 of Stat5a and
Tyr699 of Stat5b are in boldface. Arrows indicate strands, and solid bars indicate -helices, as predicted from the
molecular modeling of Stat5. Panels A and B were adapted from Fig. 1A
and B in reference 7, with the permission of
Cell and J. Kuriyan.
|
|

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 2.
Characterization of purified Stat5 proteins by Western
blotting. Baculoviruses encoding Stat5a, Stat5b, Stat5aY694F, or
Stat5aW37A were used to infect insect cells. Recombinant proteins were
purified, analyzed on sodium dodecyl sulfate-polyacrylamide gels, and
either silver stained (A) or immunoblotted by using antibodies to
Stat5a and Stat5b (Stat5; B), anti-Stat5a (C), anti-Stat5b (D), or
phosphotyrosine (PY20; E).
|
|
Optimal Stat5a and Stat5b binding sites were selected from a pool of
double-stranded oligonucleotides, as described in Materials
and
Methods. After four cycles of selection, the selected oligonucleotide
pools were PCR amplified and used as probes in binding reactions
with the selecting protein (Fig.
3).
Stat5a formed faster- and
slower-migrating complexes with the
oligonucleotide pools selected
in each cycle (Fig.
3A, lanes 1 to 4).
As expected, neither complex
formed with Stat5aY694F (lane 5), which
cannot form dimers or
bind DNA and, correspondingly, no Stat5a DNA
binding activity
was detected when the binding site selection was
performed with
Stat5aY694F protein (lane 6). The faster-migrating
complex comigrated
with Stat5a dimers, while the slower one comigrated
with tetramers
(see below). After the fourth round of selection, the
faster complex
(lane 4) was excised, PCR amplified, cloned, and
sequenced. By
aligning the sequences of 33 independent clones (Fig.
4), we established
a consensus motif for
the binding of Stat5a homodimers:
(A/g)(T/A)
TTC(C/T)N(G/a)GAA(A/tc)(T/c)
(the GAS
element is underlined; Fig.
4 shows each of the selected
sequences and
the derived consensus motif for Stat5a binding).
All of the sequences
displayed in Fig.
4 are in the same orientation
with respect to the
flanking sequences. The position of the selected
GAS motif within the
26 random nucleotides in R76 therefore appeared
to be random,
suggesting that the constant flanking sequences
did not influence the
sites that were selected.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 3.
Binding site selection for Stat5a. (A) DNA selected at
sequential cycles by Stat5a were used as probes in EMSAs with Stat5a
(lanes 1 to 4). The faster complex (F) comigrated with Stat5a dimers,
and the slower complex (S) migrated with Stat5a tetramers. Stat5aY694F
did not bind to DNA selected by the wild-type protein (lane 5) and did
not select for Stat5a binding sites (lane 6). (B) Same as for panel A,
except that Stat5b was used.
|
|

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 4.
Alignment of 33 Stat5a dimer-selected DNAs. Sequences
and nucleotide frequency in 33 binding sites selected by Stat5a
homodimers after four cycles of selection (lane 4 of Fig. 3A). Nine of
these DNAs were tested with Stat5a in EMSAs, and each bound Stat5a
dimers. Not included in the figure are 10 sequences that lacked
canonical GAS motifs, since the five of these that were tested in EMSAs
were all proven to be falsely selected sequences that could not bind
dimeric Stat5a. All sequences are shown in the same orientation
relative to the flanking sequences (top strand). The conserved
consensus GAS motif is boxed; its central nucleotide was assigned
position zero. The consensus Stat5a binding motif was derived from the
nucleotide frequencies in the binding sites in the figure. At each
position, the more-favored nucleotides are shown in upper case letters,
while less-favored nucleotides are in lower case.
|
|
Interestingly, Stat5b formed only one complex with the selected
oligonucleotides (Fig.
3B, lanes 2 to 4) that comigrated with
the
faster one formed by Stat5a (dimer). Alignment of 45 independent
oligonucleotide sequences selected by Stat5b (Fig.
5) in the fourth
cycle of selection (Fig.
3B, lane 4) yielded a consensus for Stat5b
dimers of:
(A/tg)(T/A)
TTC(C/T)(T/cag)(G/a)GAA(T/A)(T/ca)
(the
GAS element is underlined; Fig.
5 shows each of the selected
sequences
and the derived consensus motif for Stat5b binding). Thus,
both
Stat5a and Stat5b homodimers selected similar consensus GAS
motifs.
Consistent with the recognition by Stat5a and Stat5b of similar
GAS motifs, each protein could bind to the oligonucleotide pools
selected by the other (data not shown). Interestingly, formation
of the
faster mobility complex by Stat5b was favored, while the
opposite was
true for Stat5a. EMSAs performed with GAS elements
from different genes
(whey acidic protein,

-casein, oncostatin
M, serine protease
inhibitor 2.1, IL-2 response element from murine
and human IL-2R

genes, Fc

RI, M67 SIE, and cyclin D2) did not
reveal any selectivity
for binding of Stat5a versus Stat5b (data
not shown). Taken together,
our results indicate that homodimers
of Stat5a and Stat5b have similar
DNA binding specificities.

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 5.
Alignment of 45 Stat5b dimer-selected DNAs. Sequences
and nucleotide frequency in 45 binding sites selected by Stat5b
homodimers after four cycles of selection (lane 4 of Fig. 3B). Ten of
these DNAs were tested in EMSAs and shown to bind Stat5b dimers. Not
included are 27 sequences that lacked consensus GAS motifs, since the
12 of these that were tested in EMSAs were found to be falsely selected
sequences that could not bind dimeric Stat5b. All sequences are shown
in the same orientation relative to the flanking sequences (top
strand). The conserved consensus Stat5b binding motif was derived from
the nucleotide frequencies in the binding sites in the figure. At each
position, the more-favored nucleotides are shown in upper case letters,
while less-favored nucleotides are in lower case.
|
|
The amino acids that differ in Stat5a and Stat5b are predicted not
to contact DNA.
To investigate the positions of the amino acid
differences between Stat5a and Stat5b, we performed molecular modeling
studies based on the coordinates of the crystal structure of the Stat1 core bound to DNA (7). As expected based on the structures for Stat1 (7) and Stat3
(4) bound to DNA,
Stat5 proteins are predicted to bind DNA as dimers in which the two
monomers contact each other only through the phosphotyrosine-SH2 domain interaction and are related by a twofold axis of symmetry which passes
through the center of the DNA. Analogous to the situation for Stat1,
the major site of protein-DNA interaction appears to be the loop formed
by amino acids 470 to 474, which intercalates in the major groove of
DNA. Interestingly, the amino acid residues in this loop are identical
between Stat5a and Stat5b. Moreover, superimposition of the core models
for Stat5a and Stat5b (Fig. 6) predicted
that all 18 amino acid differences (see Fig. 1B) do not contact the
DNA. This is consistent with our experimental data indicating that the
DNA binding specificities of Stat5a and Stat5b are very similar.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 6.
The 18 amino acid differences between the Stat5a and
Stat5b cores appear to be remote from DNA binding surface. Superimposed
structures of human Stat5a (red) and Stat5b (yellow) core monomers were
obtained by homology modeling. The 18 amino acids which differ between
Stat5a and Stat5b (see Fig. 1B) are indicated as follows: 1, A187G; 2, Q188P; 3, A230P; 4, E391D; 5, C392Y; 6, A427S; 7, V442I; 8, S452G; 9, H476N; 10, W566R; 11, H585L; 12, P636Q; 13, N639M; 14, L640F; 15, K644M; 16, S664N; 17, F679Y; and 18, L687T. The first letter and number
represent the residue in Stat5a, while the second letter represents the
corresponding residue in Stat5b. Five residues, PCESA, are present in
Stat5b (amino acids 687 to 691) but not Stat5a.
|
|
Stat5a forms tetramers with oligonucleotides selected in the
slower-migrating complex.
Since Stat5 proteins can cooperatively
bind to tandem GAS motifs as tetramers (15, 23), we
speculated that the slower-migrating complex formed by Stat5a with the
selected oligonucleotides (Fig. 3A) was a tetramer. We therefore cloned
the DNAs that were bound to Stat5a in the slower-migrating complex
after four cycles of selection (Fig. 3A, lane 4), sequenced the
inserts, and tested 59 independent clones for their abilities to bind
Stat5a in EMSAs. The sequences of the 50 oligonucleotides that bound
Stat5a tetramers are shown in Fig. 7; the
other nine selected DNAs either did not bind Stat5a (e.g.,
oligonucleotide 982; Fig. 8B, lane 17),
or bound only as dimers (e.g., oligonucleotide 939, lane 21) and therefore were not included in Fig. 7.

View larger version (77K):
[in this window]
[in a new window]
|
FIG. 7.
Alignment of 50 Stat5a tetramer-selected DNAs. Sequences
of 50 binding sites selected by Stat5a tetramers after four cycles of
selection (lane 4 of Fig. 3A). All of the sequences shown bound Stat5a
tetramers in EMSAs. Not shown are nine sequences that were selected but
which were unable to bind Stat5 tetramers. Shown are sequences
containing a consensus GAS motif (top 18 sequences) or a nonconsensus
GAS motif (middle 25 sequences). As noted in the text, the bottom seven
sequences bound Stat5a tetramers relatively poorly. The nucleotides in
italics correspond to sequences from the nonrandom flanking sequences
of R76; these are included as the GAG in the 3' flank was shown in Fig.
11 to be important for tetrameric Stat5a binding to oligonucleotide
947. Note that this GAG was often 3 bp downstream of a TTC, thus
forming nonconsensus GAS motifs. On the right are sequence identifiers.
Those containing sequences with GASc motifs are in boldface. An "r"
before a sequence identifier indicates that the bottom rather than top
strand is shown to align the GASc or GASn shown in the open box 5' to
the more-divergent sequence shown in the shaded boxes. Underlined
numbers refer to sequences that were evaluated by EMSA in Fig. 8.
Superscripted " " and "*" symbols refer to sequences with
spacings of 5 and 7 bp between the boxed regions, respectively. The
ability of the tetramer-selected sequences to bind Stat5a as a dimer is
indicated.
|
|

View larger version (66K):
[in this window]
[in a new window]
|
FIG. 8.
Representative EMSAs from oligonucleotides selected in
the binding site selection with Stat5a corresponding to the
slower-mobility complex. The panels show binding with Stat5a (150 ng)
or an equivalent amount of mutant Stat5aW37A protein. The sequences for
the oligonucleotides used are shown in Fig. 7 except for 982 and 939 (5'-TCTTCGTGGAAGCAGCGTGGCAGGTA-3'
and
5'-TTCCTGGAAATGGATATTAGTACCCC-3',
respectively). In each oligonucleotide, the consensus GAS motif
is underlined with the TTC and GAA shown in boldface; a 9-bp segment
downstream which could represent a second divergent GAS motif is also
underlined. In each case, the similarity of these putative GAS motifs
is remote, as indicated by the nucleotides in boldface. Accordingly,
neither of these sequences bound Stat5a tetramers (panel B, lanes 17 and 21). The sequence of the PRRIII oligonucleotide is
5'-TCTTCTAGGAAGTACCAAACATTTCTGATAATA-3'.
All of the oligonucleotides also included 15 constant nucleotides
both 5' and 3' to facilitate labeling by PCR (see Materials and
Methods).
|
|
Remarkably, only 18 of the 50 tetrameric binding sites contained a
consensus TTCN
3GAA motif (GASc), while all of
the others
contained a GAS motif with a single nucleotide change from
the
TTCN
3GAA consensus (GASn). In addition to
the GASc or GASn motif
present in all 50 binding sites (Fig.
7, open
boxes, on the left),
the most striking feature, found in 33 of the
sequences, was the
presence of either a TTC or GAA half-GAS motif at a
distance of

5 bp (e.g., oligonucleotides 978, 972, and 915) away from
the
GAS motif. This spacing is presumably the minimal distance for
stable tetramer formation (reference
36 and see also
Discussion).
Notably, the majority of the TTC half-sites were located
at a
6-bp distance downstream from the GASc or GASn (e.g., 972, 924,
r926, and r957), while most of the GAA half-sites were located
12 bp
apart from the GASc or GASn (e.g., oligonucleotides r944,
915, r916,
and 941). Such a spacing is consistent with the GAA
being 6 bp
downstream of the TTC in consensus TTCN
3GAA GAS
motifs.
These observations led us to speculate that a second,
more-divergent
GAS motif spaced 6 bp from a more-conserved one (GASc or
GASn)
was responsible for the binding of one of the two dimers of
Stat5a
in the tetrameric complex. These putative divergent GAS motifs
are shown in shaded boxes in Fig.
7. For two of the binding sites
(oligonucleotides 936 and 978) such an element was located at
an
inter-GAS spacing of 5 bp, while for seven sites (oligonucleotides
934, 918, 921, 960, 909, 905, and 920) a spacing of 7 bp was seen.
Interestingly, there was greater divergence in such accessory
sites
when the sequence contained a GASc rather than a GASn motif
(compare
the nucleotides in the shaded boxes for the upper 18
sequences to the
middle 25 sequences). Many of the binding sites
which did not contain a
half-GAS motif had four of six of the
key nucleotides in GAS motifs
(e.g., oligonucleotides 930, r935,
and 923; the conserved nucleotides
are in boldface in the shaded
boxes). However, certain sequences were
more divergent and correspondingly
these were typically weak tetramer
binding sites (see below).
Overall, the nucleotide preferences of the
Stat5a tetramer were
much less stringent than those found for the
Stat5a dimer (Fig.
4), particularly related to the TTC and GAA sequence
of the GAS
elements (positions ±2, ±3, and ±4).
Representative EMSAs were performed with selected DNAs and wild-type
Stat5a or the tetramerization-defective W37A mutant of
Stat5a
(
15) (Fig.
8A and
5B). As expected, the slower-migrating
complexes were formed only with wild-type Stat5a, whereas the
faster
complexes were detected with both wild-type and W37A mutant
Stat5a
proteins, indicating that the slower complexes required
N-terminal
interactions for their formation. Consistent with this
conclusion, the
slower complexes formed by the selected oligonucleotides
comigrated
with the complex formed by PRRIII (lane 1), which contains
two tandemly
linked GAS motifs and is known to bind Stat5a tetramers
(
15). Most of the selected sites (top 43 sequences in Fig.
7)
bound Stat5a with an apparent affinity similar to that seen for
PRRIII (e.g., oligonucleotides 915, 965, and 918; Fig.
8A, lanes
3, 5, and 9 versus lane 1) or higher than that seen with PRRIII
(e.g.,
oligonucleotides 960, 925, and 910; Fig.
8A, lanes 7, 23,
and 27 versus
lane 1). A few of the selected sites (the bottom
seven sequences in
Fig.
7) bound Stat5a tetramers weakly, even
at a concentration of 150 ng (e.g., oligonucleotides 973 and 920;
Fig.
8B, lanes 15 and 19), and
no binding was detected with these
oligonucleotides when only 20 ng of
Stat5a was used. In contrast,
all 9 of the 43 higher-affinity
oligonucleotides tested (903,
916, 918, 928, 934, 941, 943, 944, and
953) could bind Stat5a
tetramers at this concentration of
Stat5a.
Nucleotide requirements for Stat5a tetramer binding.
We next
sought to determine the nucleotide requirements for formation of
tetramers. To directly test the role of the half-GAS sites in the
binding of Stat5a tetramers, we mutated them in the context of
oligonucleotides 918, 928, and 934 and evaluated these mutants (Fig.
9A, M1 mutants) for binding to Stat5a in
EMSAs (Fig. 9B). The half-GAS sites were necessary for the binding of
Stat5a tetramers to each of these oligonucleotides (lanes 5 versus 3, 9 versus 7, and 13 versus 11). Nevertheless, mutation of the half-GAS site in oligonucleotide 928 did not affect its ability to bind Stat5a
dimers, indicating that its consensus GAS was sufficient to allow the
formation of dimers (lanes 9 and 10) but not of tetramers. Correspondingly, Stat5aW37A dimers bound to either the wild-type or the
mutant 928 probes (lanes 8 and 10). This was not the case for
oligonucleotides 918 and 934, which could bind Stat5a only as tetramers
(lanes 6 and 14). The fact that tetramer formation was favored for
oligonucleotides 918, 928, and 934 (Fig. 9B, lanes 3, 7, and 11)
indicated cooperative binding.

View larger version (55K):
[in this window]
[in a new window]
|
FIG. 9.
Obligatory role of half-GAS sites present in binding
sites selected in the slower-migrating complex that corresponds to
Stat5a tetramers. (A) Schematic representation of the probes used in
the EMSAs shown in panel B. The 26 nucleotides selected by the Stat5a
slower complex in the clones analyzed (918, 928, and 934) are in plain
text, while the artificially introduced flanking nucleotides are in
italics. The nucleotide changes introduced in their mutated versions
(918M1, 928M1, and 934M1) are in lowercase letters. The consensus GAS
elements are in the open box, while the nonconsensus GAS elements are
in the shadowed boxes. Consensus half-sites are in boldface. (B) EMSAs
were performed with Stat5a (150 ng) or with an equivalent amount of
Stat5aW37A, and the probes shown in panel A, which were labeled by
Klenow fill-in.
|
|
To further elucidate the sequence requirements for tetramer formation,
we performed methylation interference assays on oligonucleotides
918 and 928 (Fig.
10).
These studies revealed the importance
of
the Gs in the "GAA" of the GASc in oligonucleotide 918 (open
boxes,
positions ± 2; Fig.
10A and D) for binding of Stat5a
tetramers.
Moreover, strong binding interference was also observed for
the
G in the half-GAS site (bottom strand, position

2), as well as
for two other Gs in the top strand (positions 0 and +1) and another
G
in the bottom strand (position +4). Thus, the half-GAS site
and these
other contacts together may functionally form a "full"
nonconsensus
binding site (shadowed box).


View larger version (6752K):
[in this window]
[in a new window]
|
FIG. 10.
Methylation interference analysis of dimeric or
tetrameric Stat5a. (A) Oligonucleotide 918 was labeled either on the
sense (TOP) or antisense (bottom [BOT]) strand, methylated with
dimethyl sulfate, and incubated with Stat5a. Shown are
piperidine-mediated cleavages of free probe (F) or of probe bound (B)
to a Stat5a tetramer. (B and C), Comparison of the nucleotide contacts
between tetrameric or dimeric Stat5a and oligonucleotide 928. The same
analysis as in panel A was performed with oligonucleotide 928, either
free (F) or bound (B) to a Stat5a tetramer (B) or to a Stat5aW37A dimer
(C). Nucleotides which interfered with binding of tetramers but not of
dimers are indicated with an arrow. Filled circles indicate strong
interference, while asterisks indicate hypermethylation. The
artificially introduced flanking nucleotides are in italics. The
consensus GAS element is in an open box, while the nonconsensus GAS
element is in a shadowed box. (D) Summary of methylation interference
analyses shown in panels A, B, and C. (E) Wild-type and mutant forms of
oligonucleotides 918 and 928. (F) The oligonucleotides in panel E were
labeled by Klenow fill-in and used in EMSAs with 150 ng of Stat5a.
|
|
To compare the nucleotides critical for binding Stat5a tetramers versus
dimers, we used oligonucleotide 928, which bound Stat5a
mainly as a
tetramer and Stat5aW37A only as a dimer (Fig.
9B,
lanes 7 and 8). The
tetrameric (Fig.
10B) and dimeric (Fig.
10C)
complexes contacted not
only the Gs in the GAA of the consensus
GAS (open boxes; positions ± 2 in Fig.
10D) but also the neighboring
G (position +1 in the
consensus GAS), a finding in agreement with
the preference for this
nucleotide observed in the binding site
selection analysis (Fig.
4).
However, only the tetramer contacted
the G at position +2 on the top
strand of the adjacent half-GAS
site and the G at position

2
(relative to this half-GAS site)
on the bottom strand. Thus, the
half-GAS site and at least one
other nucleotide were important for the
formation of Stat5a tetramers
but not
dimers.
We next mutated these nucleotide contacts in the non-consensus GAS
motif in oligonucleotides 918 and 928 (see Fig.
10E) and
evaluated
their Stat5a binding activity in EMSAs (Fig.
10F). Mutation
of the two
Gs at positions 0 and +1 in the top strand and the
one at position +4
in the bottom strand of oligonucleotide 918
(mutant 918M2; Fig.
10E)
diminished Stat5a tetramer binding (Fig.
10F, lane 2 versus 1).
Analogously, in oligonucleotide 928, mutation
of the G at position

2
in the bottom strand of the nonconsensus
GAS motif (mutant 928M2)
diminished tetramer formation without
altering dimer formation (lane 4 versus lane 3). This is consistent
with the importance of this G for
binding Stat5a tetramers but
not dimers (Fig.
10D). Thus, the half-GAS
site and the neighboring
divergent nucleotides appear to form a
nonconsensus GAS motif
that is essential for binding Stat5a tetramers.
The analysis of
additional mutants of oligonucleotide 928 (oligonucleotides 928
M3 through M7) confirmed the essential role of
the C in the TTC
and the G in the GAA of the consensus GAS motif for
both tetramer
and dimer binding (mutants M4 and M6, Fig.
10F, lanes 7 and 9 versus
lane 5), in accord with the observed strong interference
of methylation
of these residues (Fig.
10B and D). In contrast,
mutation of GT
G to GT
A in the central part of
the consensus GAS motif (M5, lane
8 versus lane 5) had no appreciable
effect on the binding of either
tetramers or dimers. Importantly,
mutant M3 showed that mutation
of the T
TC to
T
AC did not affect tetramer binding but substantially
diminished dimer binding (lane 6 versus lane 5). Finally, the
M7 mutant
confirmed the important role, as suggested by the methylation
interference analysis, of a nucleotide downstream of the GASc
for dimer
but not tetramer formation (lane 10 versus lane 5).
Thus, we have
demonstrated the greater tolerance for deviation
from consensus GAS
motifs for tetramer binding, a result consistent
with an overall larger
number of contact points with DNA than
exists for dimers, and have
identified mutants that can selectively
affect either tetramer binding
(928M1; Fig.
9B, lane 10 versus
lane 9) or dimer binding (928 M3 and M7
Fig.
10F, lanes 6 and 10
versus lane
5).
As mentioned above, certain binding sites did not contain a half-GAS
TTC or GAA sequence but nevertheless efficiently bound
Stat5a
tetramers. To clarify the basis of binding to these sequences,
we
introduced mutations in two representative oligonucleotides
(946 and
947, Fig.
11A) to understand which
nucleotides were critical
for Stat5a tetramer binding. When the
putative highly divergent
GAS motif (shaded box in Fig.
11A) in
oligonucleotide 946 was altered
from
CC
CGGA
GC
A to
CC
gGGA
GC
A (Fig.
11A),
binding activity of Stat5a
tetramers (but not dimers) was decreased
(Fig.
11B, lane 8 versus
lane 7). This confirms that a nucleotide
located within a region
that would not normally be recognized as
contributing to Stat5a
binding was important for anchoring the
tetrameric complex. We
also analyzed oligonucleotide 947 in which both
GAS motifs are
nonconsensus motifs and where the downstream GASn
includes the
GAG from the constant R76 flanking sequence.
Interestingly, each
of the four putative half-GAS sites were important
for binding
of Stat5a tetramers, as shown by the strong reduction in
binding
shown by mutants 947 M1 to M4 (Fig.
11A; Fig.
11B, lane 2 versus
lane 1 and lanes 4 to 6 versus lane 3). This also confirms that
the GAG in the constant flanking sequence was often involved in
Stat5a
tetramer binding when separated by three nucleotides from
a TTC or TAC,
as occurred in a number of the selected oligonucleotides
(Fig.
7; e.g.,
oligonucleotides 917, 906, and 932). This is in
contrast to the random
positioning of a single GAS motif within
the random 26 nucleotides in
the Stat5a dimer-selected sequences
(Fig.
4).

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 11.
Critical role of nucleotides which do not form half-GAS
sites for binding of Stat5a tetramers. (A) Sequences of wild-type and
mutant forms of oligonucleotides 946 and 947. (B) EMSAs performed with
the oligonucleotides in panel A were labeled by PCR (see Materials and
Methods) and 150 ng of Stat5a.
|
|
A spacing of 6 bp between GAS sites is optimal for tetramer
formation.
As noted above, many oligonucleotides selected in the
slower migrating complex of Stat5a contained a GAS (consensus and/or nonconsensus) motif separated by 6 or 7 bp from an often more divergent
motif (Fig. 7). Since the length of the random sequence of the
oligonucleotide pool used in the binding site selection was 26 bp, the
maximal distance between two 9-bp GAS elements that we could detect is
8 bp (actually, a slightly greater spacing could have been seen because
of the use of the GAG in the 3' flanking sequence as an alternate to a
GAA half-site in some sequences such as oligonucleotide 947). To
overcome this bias, we synthesized a series of mutants of
oligonucleotide 928 in which the number of base pairs between the GAS
motifs ranged between 1 and 19 (Fig. 12A) and used them as probes in EMSAs
with Stat5a. For a spacing of greater than 6 bp, additional nucleotides
were inserted within the six inter-GAS motif nucleotides. Based on
methylation interference, there was no evidence that the six inter-GAS
residues contributed to tetramer binding (Fig. 10B), although this
possibility is not excluded since methylation interference assays only
can evaluate the importance of G and A residues. As shown in Fig. 12B
and consistent with the binding site selection analysis, distances less
than 6 bp did not allow efficient tetramer binding (lanes 1 to 3), while a spacing of 6 bp was optimal (lane 4). Spacing greater than 6 bp
showed weaker but visible tetramer formation (lanes 5 to 14). As
expected, the variation in the inter-GAS spacing had no effect on dimer
binding (lanes 1 to 14). Interestingly, for two oligonucleotides tested
(918 and 934), a spacing of 7 bp was as efficient as a spacing of 6 bp
(data not shown). We extended this analysis by comparing a spacing of 6 versus 11 bp for oligonucleotide 918 and for the naturally occurring
tandem GAS elements in PRRIII (ref. 15; Fig. 12C).
In both cases, a spacing of 6 bp was much more efficient in allowing
Stat5a tetramer formation than was a spacing of 11 bp (Fig. 12D, lanes
1 and 3 versus lanes 2 and 4). Thus, a spacing of 6 bp (and in some
cases also of 7 bp, depending on the nucleotide context) between GAS motifs allowed maximal binding of Stat5a tetramers in vitro. Although the binding site selection identified a few sequences with an inter-GAS
spacing of 5 bp, it appears that tetramers are more favored at a
spacing of at least 6 bp, possibly due to steric hindrance at a spacing
of less than 5 bp. This is consistent with the observation that Stat1
tetramer binding was unstable at a spacing of 5 bp (36). It
is possible that optimal binding is seen at a spacing of 6 bp rather
than at larger distances due to additional stabilizing interactions
that do not occur with a larger spacing (see Discussion). Nevertheless,
Stat5 tetramers can form at greater distances. For example, Stat5
tetramers can physiologically interact with an element such as PRRIII
(spacing of 11; see reference 15).

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 12.
A spacing of 6 bp between GAS sites is optimal for
Stat5a tetramer formation. (A) Schematic representation of the probes
used in EMSAs shown in panel B. This series of oligonucleotides was
based on oligonucleotide 928 (see Fig. 9A for the artificially
introduced flanking nucleotides), in which the consensus (open box) and
nonconsensus (shadowed box) GAS elements were 6 bp apart. This spacing
was varied either by removing intermediate base pairs (spacing of 1, 3, or 5 bp) or by adding them (lowercase letters, spacing of 7 bp). (B)
EMSAs were performed with 20 ng of Stat5a and the probes shown in panel
A. (C) Schematic representation of the probes used in EMSAs shown in
panel D; see Fig. 9A for the artificially introduced flanking
nucleotides. The distance between the consensus (open box) and
nonconsensus (shadowed box) GAS elements present in oligonucleotide 918 (7 bp) was either reduced to 6 bp (lane 1) or increased to 11 bp (lane
2). The naturally occurring inter-GAS distance of 11 bp in PRRIII (lane
4) was reduced to 6 bp (lane 3). Stat5a was used at 150 ng in EMSAs
shown in lanes 1 and 2 and 20 ng for lanes 3 and 4. Probes were labeled
by Klenow fill-in.
|
|
 |
DISCUSSION |
Based on the phenotype of Stat5a
/
,
Stat5b
/
, and Stat5a
/
Stat5b
/
mice, Stat5a and Stat5b appear to mediate both
overlapping and distinct functions. For this reason and because of the
amino acid differences in the Stat5a and Stat5b DNA binding domains, we
had anticipated that we might identify differences in the preferred binding sites for homodimers of these two proteins. However, we found
similar optimal binding sites for human Stat5a and Stat5b homodimers
(Fig. 4 and 5). Thus, our data do not provide a basis for the different
roles of these STATs based on differences in DNA binding specificity of
Stat5a versus Stat5b homodimers. The similarity in the optimal binding
sites for Stat5a and Stat5b is consistent with the prediction that the
amino acids that differ in these proteins do not contact DNA, as
indicated by our modeling studies of the Stat5a versus Stat5b cores
(Fig. 6). However, since the motifs that we have defined represent
optimal binding sites, it is possible that lower-affinity sites that
are selective for Stat5a versus Stat5b binding might exist. The
presence of a glycine at residue 433 in murine Stat5b versus a glutamic
acid in Stat5a has been reported to confer distinct DNA binding
specificities (6). However, all published human Stat5a and
Stat5b proteins have a Glu at this position (12, 19, 31),
suggesting that the Gly versus Glu results are not relevant to
potential binding differences between human Stat5a and Stat5b.
Furthermore, Gly433 in murine Stat5b (20) was
Glu433 in the two other murine Stat5b sequences (1,
26). It is possible, however, that Stat5a and Stat5b could exert
different actions based on potential differences (i) in their
expression levels in different cellular lineages, (ii) in the
efficiency of their respective recruitment and activation in response
to different stimuli, (iii) in their abilities to interact with other transcription factors and/or coactivators, or (iv) in their abilities to form tetramers. Indeed, the most striking difference between the
Stat5a and Stat5b selections was the absence of a tetrameric complex
for Stat5b. This may reflect that Stat5b bound DNA less efficiently
than Stat5a (Fig. 3B versus 3A) even though both proteins showed
comparable levels of tyrosine phosphorylation (Fig. 2E, lane 2 versus
1), or that Stat5b is intrinsically less efficient at forming
tetramers, as suggested by Verdier et al. (35). Consistent with this possibility, we reproducibly have observed less Stat5b than
Stat5a tetramer DNA binding activity in nuclear extracts prepared by
using a 293T cell-based IL-2-induced Stat5 binding reconstitution
system (reference 15 and data not shown).
We also established the sequence requirements for the binding of Stat5a
tetramers to DNA. We found that there are consensus GAS motifs that do
not bind Stat5a except when tandemly linked to a TTC or GAA half-GAS
site (Fig. 9). TTC or GAA half-GAS sites appear to be able to function
as part of nonconsensus "full" GAS motifs, since other nucleotides
are also important to anchor the tetrameric complex to DNA (e.g.,
oligonucleotides 918 and 928). This is consistent with the degree of
divergence of nonconsensus GAS motifs that were selected (Fig. 7).
Indeed, mutational analysis of oligonucleotide 928, which can bind
Stat5a dimers and tetramers, revealed that it was possible to introduce
specific mutations that virtually abolished the binding of Stat5a as
dimers without affecting its binding as tetramers (Fig. 10). This
diminished nucleotide stringency is presumably allowed by the increased
cooperativity of binding fostered by tetramerization. Conversely, we
have previously shown that improving the affinity of imperfect GAS
motifs can compensate for defective tetramerization of the W37A mutant
of Stat5a (15). Thus, the overall stability of the
tetrameric complex is due to DNA-protein as well as to protein-protein interactions.
It was striking that none of the selected sequences contained two
consensus GAS motifs even though we have confirmed that sequences
containing two consensus GAS motifs can efficiently bind Stat5
tetramers (reference 15 and data not shown). We
hypothesize that the fact that such sequences were not identified
reflects the large range of tandem imperfect GAS-like sequences that
can bind, in accord with considerable flexibility in the binding motifs for tetramers, and that such sequences would be identified if a
sufficiently large number of tetrameric binding sites were sequenced.
For the binding of Stat5a tetramers, an inter-GAS spacing of less than
5 bp was not favored and a spacing of 6 bp appeared optimal.
Presumably, this reflects steric interference that occurs at short
distances. Although the random oligonucleotide used in the binding site
selection could allow one to observe a larger spacing (up to 8 bp
within the random core and up to 11 bp if one allows for the
utilization of the GAG in the 3' flank as an acceptable 3' end of a GAS
motif), spacing above 7 bp was not seen. The only exception to this may
be oligonucleotide r944 which has a TTC at a spacing of 15 bp but which
also has a TTTN3GAA motif at the typical spacing
of 6 (Fig. 7).
To further understand Stat5a binding as a tetramer, we used our model
of the Stat5a core dimer bound to DNA (based on the Stat1 structure;
see Methods) to build a model which could accommodate the independent
binding of two core dimers of Stat5a to oligonucleotide 928 in which
the GAS motifs are 6 bp apart. In this model, the two Stat5a dimer
cores were positioned at a distance so that they could potentially form
contacts. If proven to be correct, this predicted protein-protein
interaction could further stabilize the tetrameric complex, providing a
molecular basis for the efficient tetramerization observed at a spacing
of approximately 6 bp and potentially decreasing the stringency for
nucleotide requirements in the DNA. In contrast, at a spacing of 11 bp
the distance between the two adjacent Stat5a core dimers was predicted
to be large enough so that these additional interactions could not
occur, lowering the predicted stability of the complex.
The relevance of the optimal binding of Stat5 to GAS elements 6 or 7 bp
apart observed in vitro for Stat5-driven transcription has not been
fully elucidated. A single copy of oligonucleotide 918 or 928 linked to
a minimal cytomegalovirus promoter could drive transcription of the
luciferase reporter gene in a Stat5-dependent manner in response to
IL-2 in a 293T cell reconstitution system (data not shown), showing
that a Stat5 tetramer bound to these elements is transcriptionally
active. We also compared the activity of a 928 reporter oligonucleotide
(spacing of 6 bp) to one with a spacing of 11 bp. Although transfection
of a Stat5 expression vector resulted in significantly higher activity
of the former construct (spacing of 6 bp) than the latter construct
(spacing of 11 bp), the basal activity of the former construct was also higher, so that the fold induction at the two different spacings was
similar. We hypothesize that the higher basal level at a spacing of 6 bp may result from the presence of low levels of endogenous activated
Stat5 in 293T cells; thus, the similar fold induction but higher
absolute level of the construct with a spacing of 6 bp might have been
predicted. It is interesting that transcription of the serine protease
inhibitor 2.1 (Spi2.1) gene has been shown to depend on the cooperative
binding of Stat5 to a consensus and a nonconsensus GAS elements 6 bp
apart (5; see Fig. 13 for the sequence).
Nonconsensus GAS motifs 6 or 7 bp apart from a consensus GAS are
present in other Stat5-responsive genes (Fig.
13). Whether Stat5 binds to these
sequences as tetramers and whether this is important for the
transcriptional regulation of these genes awaits direct testing.
Interestingly, formation of a tetrameric Stat5 complex is essential for
the IL-2-inducible activation of PRRIII (15), which has a
natural spacing of 11 bp between its GAS motifs. In PRRIII, the
sequences flanking the GAS motifs bind important accessory factors that
are critical for maximal transcriptional activation. This is in accord
with transcriptional activation of eukaryotic genes involving the
assembly of multiprotein complexes which, at least in some cases,
requires a highly specific three-dimensional architecture
(33). In this regard, in the context of the murine IL-2R
gene, while increasing the naturally occurring inter-GAS spacing from
11 to 16 bp strongly reduced the IL-2-driven transcription, increasing
it to 21 bp fully maintained its transcriptional activity (23). These results might be explained by the very different three-dimensional structures formed by Stat5 tetramers that are bound
to GAS elements spaced so that the two dimers are on opposite sides of
the DNA (inter-GAS spacing of 6 bp; the same relative orientation as at
a 16-bp spacing) versus the structure in which Stat5 dimers are bound
on the same side of the DNA (inter-GAS spacing of 11 bp; same as at a
21-bp spacing).

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 13.
Putative tetramer binding sites in Stat5 responsive
gene. An "r" before the sequence name indicates that the bottom
rather than top strand is shown to align the GASc shown in the open box
5' to the more divergent sequence shown in the shaded boxes, analogous
to the sequences in Fig. 7. The numbers in parentheses are the
references from which the sequences were derived; for porcine
-casein, a GenBank accession number is shown.
|
|
Interestingly, the consensus GAS motifs selected by Stat5a and Stat5b
dimers are relatively similar to those reported for Stat1, Stat3, and
Stat4 (11, 39), although in each of these cases the core GAS
motif was TTCCSGGAA, while it was
TTCYNRGAA for both Stat5a and Stat5b. Because
these analyses were performed in different labs, it is unclear whether
these differences correspond to distinct binding specificities or
simply reflect differences in the stringency of selection. However, all
of these differ from the optimal site selected by Stat6
(TTCNTNGGAA [reference 30 and data not shown]), which has a spacing of four nucleotides rather than three between the two half-GAS motifs (30).
Optimal sites for tetrameric binding of Stat1, Stat3, Stat4, and Stat6 have not been reported and therefore a comparison of tetrameric STAT
binding is not yet possible. However, presumably differences in
affinity and specificity for different STATs may help to determine the
cytokines which can activate the transcription of specific target genes.
In conclusion, our data indicate that the repertoire of potential
binding sites for Stat5a is broader than expected, a finding likely to
be relevant to other STATs. It is possible that different spacing of
GAS motifs may also influence the degree of STAT-mediated DNA bending,
which could also influence the potency of STAT-induced transcriptional
activation of target genes. The existence of naturally occurring
suboptimal GAS sites and variable spacing between them may represent
strategies that allow greater specificity by requiring cooperative
binding of STAT oligomers. In turn, this could also influence the
ability of STAT proteins to interact with other components of the
transcription machinery.
 |
ACKNOWLEDGMENTS |
We thank Enrico Balducci for valuable discussions and support,
David Margulies, Jian-Xin Lin, and Anne Puel for critical comments on
the manuscript and Maria Berg for technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratory of
Molecular Immunology, Bldg. 10, Rm. 7N252, NHLBI, NIH, Bethesda, MD
20892-1674. Phone: (301) 496-0098. Fax: (301) 402-0971. E-mail:
wjl{at}helix.nih.gov.
Present address: IRIS, Chiron Biocine, Via Fiorentina 1, 53100 Siena, Italy.
Present address: Molecular Modeling Section, Pharmaceutical
Science Department, University of Padova, 35100 Padova, Italy.
 |
REFERENCES |
| 1.
|
Azam, M.,
H. Erdjument-Bromage,
B. L. Kreider,
M. Xia,
F. Quelle,
R. Basu,
C. Saris,
P. Tempst,
J. N. Ihle, and C. Schindler.
1995.
Interleukin-3 signals through multiple isoforms of Stat5.
EMBO J.
14:1402-1411[Medline].
|
| 2.
|
Baldwin, A. S. J.
1987.
Methylation interference assay for analysis of DNA-protein interactions, p. 12.3.1-12.3.4.
In
F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2. Greene Publishing Associates/Wiley-Interscience, New York, N.Y
|
| 3.
|
Beadling, C.,
J. Ng,
J. W. Babbage, and D. A. Cantrell.
1996.
Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway.
EMBO J.
15:101-112.
|
| 4.
|
Becker, S.,
B. Groner, and C. W. Muller.
1998.
Three-dimensional structure of the Stat3 homodimer bound to DNA.
Nature
394:145-151[CrossRef][Medline].
|
| 5.
|
Bergad, P. L.,
H.-M. Shih,
H. C. Towle,
S. J. Schwarzenberg, and S. A. Berry.
1995.
Growth hormone induction of hepatic serine protease inhibitor 2.1 transcription is mediated by a Stat5-related factor binding synergistically to two -activated sites.
J. Biol. Chem.
270:24903-24910[Abstract/Free Full Text].
|
| 6.
|
Boucheron, C.,
S. Dumon,
S. C. R. Santos,
R. Moriggl,
L. Hennighausen,
S. Gisselbrecht, and F. Gouilleux.
1998.
A single amino acid in the DNA binding regions of STAT5A and STAT5B confers distinct DNA binding specificities.
J. Biol. Chem.
273:33936-33941[Abstract/Free Full Text].
|
| 7.
|
Chen, X.,
U. Vinkemeier,
Y. Zhao,
D. Jeruzalmi,
J. E. Darnell, Jr., and J. Kuriyan.
1998.
Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA.
Cell
93:827-839[CrossRef][Medline].
|
| 8.
|
Darnell, J. E., Jr.
1997.
STATs and gene regulation.
Science
277:1630-1635[Abstract/Free Full Text].
|
| 9.
|
Decker, T.,
P. Kovarik, and A. Meinke.
1997.
GAS elements: A few nucleotides with a major impact on cytokine-induced gene expression.
J. Interferon Cytokine Res.
17:121-134[Medline].
|
| 10.
|
Grillot, D. A. M.,
M. González-García,
D. Ekhterae,
L. Duan,
N. Inohara,
S. Otha,
M. F. Seldin, and G. Núñez.
1997.
Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene.
J. Immunol.
158:4750-4757[Abstract].
|
| 11.
|
Horvath, C. M.,
Z. Wen, and J. E. Darnell, Jr.
1995.
A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain.
Genes Dev.
9:984-994[Abstract/Free Full Text].
|
| 12.
|
Hou, J.,
U. Schindler,
W. J. Henzel,
S. C. Wong, and McKnight.
1995.
Identification and purification of human Stat proteins activated in response to interleukin-2.
Immunity
2:321-329[CrossRef][Medline].
|
| 13.
|
Ihle, J. N.
1996.
STATs: signal transducers and activators of transcription.
Cell
84:331-334[CrossRef][Medline].
|
| 14.
|
Imada, K.,
E. T. Bloom,
H. Nakajima,
J. A. Horvath-Arcidiacono,
G. B. Udy,
H. Davey, and W. J. Leonard.
1998.
Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity.
J. Exp. Med.
188:2067-2074[Abstract/Free Full Text].
|
| 15.
|
John, S.,
U. Vinkemeier,
E. Soldaini,
J. E. Darnell, Jr., and W. J. Leonard.
1999.
The significance of tetramerization in promoter recruitment by Stat5.
Mol. Cell. Biol.
19:1910-1918[Abstract/Free Full Text].
|
| 16.
|
Laskowski, R. A.,
M. W. Macarthur,
D. S. Moss, and J. M. Thornton.
1993.
PROCHECK a program to check the stereochemical quality of protein structures.
J. Appl. Crystallogr.
26:283-291[CrossRef].
|
| 17.
|
Leonard, W. J., and J. J. O'Shea.
1998.
Jaks and STATs: Biological implications.
Annu. Rev. Immunol.
16:293-322[CrossRef][Medline].
|
| 18.
|
Levitt, M.,
M. Hirshberg,
R. Sharon, and V. Daggett.
1995.
Potential-energy function and parameters for simulations of the molecular-dynamics of proteins and nucleic-acids in solution.
Comput. Phys. Commun.
91:215-231[CrossRef].
|
| 19.
|
Lin, J.-X.,
J. Mietz,
W. S. Modi,
S. John, and W. J. Leonard.
1996.
Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells.
J. Biol. Chem.
271:10738-10744[Abstract/Free Full Text].
|
| 20.
|
Liu, X.,
G. W. Robinson,
F. Gouilleux,
B. Groner, and L. Hennighausen.
1995.
Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue.
Proc. Natl. Acad. Sci. USA
92:8831-8835[Abstract/Free Full Text].
|
| 21.
|
Liu, X.,
G. W. Robinson,
K. U. Wagner,
L. Garrett,
A. Wynshaw-Boris, and L. Hennighausen.
1997.
Stat5a is mandatory for adult mammary gland development and lactogenesis.
Genes Dev.
9:2266-2278[Abstract/Free Full Text].
|
| 22.
|
Meeker, T. C.,
J. Loeb,
M. Ayres, and W. Sellers.
1990.
The human Pim-1 gene is selectively transcribed in different hemato-lymphoid cell lines in spite of a G+C-rich housekeeping promoter.
Mol. Cell. Biol.
10:1680-1688[Abstract/Free Full Text].
|
| 23.
|
Meyer, W. K.-H.,
P. Reichenbach,
U. Schindler,
E. Soldaini, and M. Nabholz.
1997.
Interaction of STAT5 dimers on two low affinity binding sites mediates interleukin 2 (IL-2) stimulation of IL-2 receptor gene transcription.
J. Biol. Chem.
272:31821-31828[Abstract/Free Full Text].
|
| 24.
|
Mohamadi, F.,
N. G. J. Richards,
W. C. Guida,
R. Liskamp,
M. Lipton,
C. Caufield,
G. Chang,
T. Hendrickson, and W. C. Still.
1990.
MacroModel-An integrated software system for modeling organic and bioorganic molecules using molecular mechanics.
J. Comput. Chem.
11:440-450[CrossRef].
|
| 25.
|
Moriggl, R.,
D. J. Topham,
S. Teglund,
V. Sexl,
C. McKay,
D. Wang,
A. Hoffmeyer,
J. van Deursen,
M. Y. Sangster,
K. D. Bunting,
G. C. Grosveld, and J. N. Ihle.
1999.
Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells.
Immunity
10:249-259[CrossRef][Medline].
|
| 26.
|
Mui, A. L.,
H. Wakao,
A. M. O'Farrell,
N. Harada, and A. Miyajima.
1995.
Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologues.
EMBO J.
14:1166-1175[Medline].
|
| 27.
|
Nakajima, H.,
X. W. Liu,
A. Wynshaw-Boris,
L. A. Rosenthal,
K. Imada,
D. S. Finbloom,
L. Hennighausen, and W. J. Leonard.
1997.
An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor chain induction.
Immunity
7:691-701[CrossRef][Medline].
|
| 28.
|
Needleman, S. B., and C. D. Wunsch.
1970.
A general method applicable to the search for similarities in the amino acid sequence of two proteins.
J. Mol. Biol.
48:443-453[CrossRef][Medline].
|
| 29.
|
Pollock, R., and R. Treisman.
1990.
A sensitive method for the determination of protein-DNA binding specificities.
Nucleic Acids Res.
18:6197-6204[Abstract/Free Full Text].
|
| 30.
|
Schindler, U.,
P. Wu,
M. Rothe,
M. Brasseur, and S. L. McKnight.
1995.
Components of a Stat recognition code: evidence for two layers of molecular selectivity.
Immunity
2:689-697[CrossRef][Medline].
|
| 31.
|
Silva, C. M., and H. Lu.
1996.
Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone.
Mol. Endocrinol.
10:508-518[Abstract/Free Full Text].
|
| 31a.
|
Socolovsky, M.,
A. E. Fallon,
S. Wang,
C. Brugnara, and H. F. Lodish.
1999.
Fetal anemia and apoptosis of red cell progenitors in Stat5a / 5b / mice: a direct role for Stat5 in Bcl-X(L) induction.
Cell
98:181-191[CrossRef][Medline].
|
| 32.
|
Teglund, S.,
C. McKay,
E. Schuetz,
J. M. van Dursen,
D. Stravopodis,
D. Wang,
M. Brown,
S. Bodner,
G. Grosveld, and J. N. Ihle.
1998.
Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses.
Cell
93:841-850[CrossRef][Medline].
|
| 33.
|
Tijan, R., and T. Maniatis.
1994.
Transcriptional activation: a complex puzzle with few easy pieces.
Cell
77:5-8[CrossRef][Medline].
|
| 34.
|
Udy, G. B.,
R. P. Towers,
R. G. Snell,
R. J. Wilkins,
S.-H. Park,
P. A. Ram,
D. J. Waxman, and H. W. Davey.
1997.
Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression.
Proc. Natl. Acad. Sci. USA
94:7239-7244[Abstract/Free Full Text].
|
| 35.
|
Verdier, F.,
R. Rabionet,
F. Gouilleux,
C. Beisenherz-Huss,
P. Varlet,
O. Muller,
P. Mayeux,
C. Lacombe,
S. Gisselbrecht, and S. Chretien.
1998.
A sequence of the CIS promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B.
Mol. Cell. Biol.
18:5852-5860[Abstract/Free Full Text].
|
| 36.
|
Vinkemeier, U.,
S. L. Cohen,
I. Moarefi,
B. T. Chait,
J. Kuriyan, and J. E. Darnell, Jr.
1996.
DNA binding of in vitro activated Stat1a, Stat1b and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites.
EMBO J.
15:5616-5626[Medline].
|
| 37.
|
Vinkemeier, U.,
I. Moarefi,
J. E. Darnell, Jr., and J. Kuriyan.
1998.
Structure of the amino-terminal protein interaction domain of Stat4.
Science
279:1048-1052[Abstract/Free Full Text].
|
| 38.
|
Weiner, S. J.,
P. A. Kollman,
D. T. Nguyen, and D. A. Case.
1986.
An all-atom force field for stimulation of protein and nucleic acids.
J. Comput. Chem.
7:230-252[CrossRef].
|
| 39.
|
Xu, X.,
Y.-L. Sun, and T. Hoey.
1996.
Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain.
Science
273:794-797[Abstract].
|
| 40.
|
Ye, S.-K.,
K. Maki,
T. Kitamura,
S. Sunaga,
K. Akashi,
J. Domen,
I. L. Weissman,
T. Honjo, and K. Ikuta.
1999.
Induction of germline transcription in the TCR locus by Stat5: implications for accessibility control by the IL-7 receptor.
Immunity
11:213-223[CrossRef][Medline].
|
Molecular and Cellular Biology, January 2000, p. 389-401, Vol. 20, No. 1
0270-7306/0/$04.00+0
This article has been cited by other articles:
-
Pappas, D. J., Coppola, G., Gabatto, P. A., Gao, F., Geschwind, D. H., Oksenberg, J. R., Baranzini, S. E.
(2009). Longitudinal system-based analysis of transcriptional responses to type I interferons. Physiol. Genomics
38: 362-371
[Abstract]
[Full Text]
-
Laz, E. V., Sugathan, A., Waxman, D. J.
(2009). Dynamic in Vivo Binding of STAT5 to Growth Hormone-Regulated Genes in Intact Rat Liver. Sex-Specific Binding at Low- But Not High-Affinity STAT5 Sites. Mol. Endocrinol.
23: 1242-1254
[Abstract]
[Full Text]
-
Waxman, D. J., Holloway, M. G.
(2009). Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes. Mol. Pharmacol.
76: 215-228
[Abstract]
[Full Text]
-
Okumura, A. J., Peterson, L. F., Okumura, F., Boyapati, A., Zhang, D.-E.
(2008). t(8;21)(q22;q22) fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expression. Blood
112: 1392-1401
[Abstract]
[Full Text]
-
Wauthier, V., Waxman, D. J.
(2008). Sex-Specific Early Growth Hormone Response Genes in Rat Liver. Mol. Endocrinol.
22: 1962-1974
[Abstract]
[Full Text]
-
Tan, S.-H., Nevalainen, M. T
(2008). Signal transducer and activator of transcription 5A/B in prostate and breast cancers. Endocr Relat Cancer
15: 367-390
[Abstract]
[Full Text]
-
Basham, B., Sathe, M., Grein, J., McClanahan, T., D'Andrea, A., Lees, E., Rascle, A.
(2008). In vivo identification of novel STAT5 target genes. Nucleic Acids Res
36: 3802-3818
[Abstract]
[Full Text]
-
Yang, X. P., Mattagajasingh, S., Su, S., Chen, G., Cai, Z., Fox-Talbot, K., Irani, K., Becker, L. C.
(2007). Fractalkine Upregulates Intercellular Adhesion Molecule-1 in Endothelial Cells Through CX3CR1 and the Jak Stat5 Pathway. Circ. Res.
101: 1001-1008
[Abstract]
[Full Text]
-
Clodfelter, K. H., Miles, G. D., Wauthier, V., Holloway, M. G., Zhang, X., Hodor, P., Ray, W. J., Waxman, D. J.
(2007). Role of STAT5a in regulation of sex-specific gene expression in female but not male mouse liver revealed by microarray analysis. Physiol. Genomics
31: 63-74
[Abstract]
[Full Text]
-
Weinhaus, A. J, Stout, L. E, Bhagroo, N. V, Brelje, T C., Sorenson, R. L
(2007). Regulation of glucokinase in pancreatic islets by prolactin: a mechanism for increasing glucose-stimulated insulin secretion during pregnancy. J Endocrinol
193: 367-381
[Abstract]
[Full Text]
-
Holloway, M. G., Cui, Y., Laz, E. V., Hosui, A., Hennighausen, L., Waxman, D. J.
(2007). Loss of Sexually Dimorphic Liver Gene Expression upon Hepatocyte-Specific Deletion of Stat5a-Stat5b Locus. Endocrinology
148: 1977-1986
[Abstract]
[Full Text]
-
Vidal, O. M., Merino, R., Rico-Bautista, E., Fernandez-Perez, L., Chia, D. J., Woelfle, J., Ono, M., Lenhard, B., Norstedt, G., Rotwein, P., Flores-Morales, A.
(2007). In Vivo Transcript Profiling and Phylogenetic Analysis Identifies Suppressor of Cytokine Signaling 2 as a Direct Signal Transducer and Activator of Transcription 5b Target in Liver. Mol. Endocrinol.
21: 293-311
[Abstract]
[Full Text]
-
Burchill, M. A., Yang, J., Vogtenhuber, C., Blazar, B. R., Farrar, M. A.
(2007). IL-2 Receptor beta-Dependent STAT5 Activation Is Required for the Development of Foxp3+ Regulatory T Cells. J. Immunol.
178: 280-290
[Abstract]
[Full Text]
-
Weaver, A. M., Silva, C. M.
(2006). Modulation of Signal Transducer and Activator of Transcription 5b Activity in Breast Cancer Cells by Mutation of Tyrosines within the Transactivation Domain. Mol. Endocrinol.
20: 2392-2405
[Abstract]
[Full Text]
-
Chia, D. J., Ono, M., Woelfle, J., Schlesinger-Massart, M., Jiang, H., Rotwein, P.
(2006). Characterization of Distinct Stat5b Binding Sites That Mediate Growth Hormone-stimulated IGF-I Gene Transcription. J. Biol. Chem.
281: 3190-3197
[Abstract]
[Full Text]
-
Ma, F. Y., Anderson, G. M., Gunn, T. D., Goffin, V., Grattan, D. R., Bunn, S. J.
(2005). Prolactin Specifically Activates Signal Transducer and Activator of Transcription 5b in Neuroendocrine Dopaminergic Neurons. Endocrinology
146: 5112-5119
[Abstract]
[Full Text]
-
Hogan, J. C., Stephens, J. M.
(2005). The Regulation of Fatty Acid Synthase by STAT5A. Diabetes
54: 1968-1975
[Abstract]
[Full Text]
-
Zhang, Q., Wang, H. Y., Marzec, M., Raghunath, P. N., Nagasawa, T., Wasik, M. A.
(2005). STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc. Natl. Acad. Sci. USA
102: 6948-6953
[Abstract]
[Full Text]
-
Moucadel, V., Constantinescu, S. N.
(2005). Differential STAT5 Signaling by Ligand-dependent and Constitutively Active Cytokine Receptors. J. Biol. Chem.
280: 13364-13373
[Abstract]
[Full Text]
-
Wang, Y., Jiang, H.
(2005). Identification of a Distal STAT5-binding DNA Region That May Mediate Growth Hormone Regulation of Insulin-like Growth Factor-I Gene Expression. J. Biol. Chem.
280: 10955-10963
[Abstract]
[Full Text]
-
Wiwi, C. A., Waxman, D. J.
(2005). Role of Hepatocyte Nuclear Factors in Transcriptional Regulation of Male-specific CYP2A2. J. Biol. Chem.
280: 3259-3268
[Abstract]
[Full Text]
-
Gonsky, R., Deem, R. L., Bream, J., Young, H. A., Targan, S. R.
(2004). Enhancer Role of STAT5 in CD2 Activation of IFN-{gamma} Gene Expression. J. Immunol.
173: 6241-6247
[Abstract]
[Full Text]
-
Bream, J. H., Hodge, D. L., Gonsky, R., Spolski, R., Leonard, W. J., Krebs, S., Targan, S., Morinobu, A., O'Shea, J. J., Young, H. A.
(2004). A Distal Region in the Interferon-{gamma} Gene Is a Site of Epigenetic Remodeling and Transcriptional Regulation by Interleukin-2. J. Biol. Chem.
279: 41249-41257
[Abstract]
[Full Text]
-
Meyer, T., Hendry, L., Begitt, A., John, S., Vinkemeier, U.
(2004). A Single Residue Modulates Tyrosine Dephosphorylation, Oligomerization, and Nuclear Accumulation of Stat Transcription Factors. J. Biol. Chem.
279: 18998-19007
[Abstract]
[Full Text]
-
Magne, S., Caron, S., Charon, M., Rouyez, M.-C., Dusanter-Fourt, I.
(2003). STAT5 and Oct-1 Form a Stable Complex That Modulates Cyclin D1 Expression. Mol. Cell. Biol.
23: 8934-8945
[Abstract]
[Full Text]
-
Hou, Z., Srivastava, S., Mistry, M. J., Herbst, M. P., Bailey, J. P., Horseman, N. D.
(2003). Two Tandemly Linked Interferon-{gamma}-Activated Sequence Elements in the Promoter of Glycosylation-Dependent Cell Adhesion Molecule 1 Gene Synergistically Respond to Prolactin in Mouse Mammary Epithelial Cells. Mol. Endocrinol.
17: 1910-1920
[Abstract]
[Full Text]
-
Kabotyanski, E. B., Rosen, J. M.
(2003). Signal Transduction Pathways Regulated by Prolactin and Src Result in Different Conformations of Activated Stat5b. J. Biol. Chem.
278: 17218-17227
[Abstract]
[Full Text]
-
Friedrichsen, B. N., Richter, H. E., Hansen, J. A., Rhodes, C. J., Nielsen, J. H., Billestrup, N., Moldrup, A.
(2003). Signal Transducer and Activator of Transcription 5 Activation Is Sufficient to Drive Transcriptional Induction of Cyclin D2 Gene and Proliferation of Rat Pancreatic {beta}-Cells. Mol. Endocrinol.
17: 945-958
[Abstract]
[Full Text]
-
Mohrs, M., Lacy, D. A., Locksley, R. M.
(2003). Stat Signals Release Activated Naive Th Cells from an Anergic Checkpoint. J. Immunol.
170: 1870-1876
[Abstract]
[Full Text]
-
Buitenhuis, M., Baltus, B., Lammers, J.-W. J., Coffer, P. J., Koenderman, L.
(2003). Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells. Blood
101: 134-142
[Abstract]
[Full Text]
-
Helander, H., Gustafsson, J.-A., Mode, A.
(2002). Possible Involvement of Truncated Signal Transducer and Activator of Transcription-5 in the GH Pattern-Dependent Regulation of CYP2C12 Gene Expression in Rat Liver. Mol. Endocrinol.
16: 1598-1611
[Abstract]
[Full Text]
-
Dong, S., Tweardy, D. J.
(2002). Interactions of STAT5b-RARalpha , a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways. Blood
99: 2637-2646
[Abstract]
[Full Text]
-
Park, S.-H., Yamashita, H., Rui, H., Waxman, D. J.
(2001). Serine Phosphorylation of GH-Activated Signal Transducer and Activator of Transcription 5a (STAT5a) and STAT5b: Impact on STAT5 Transcriptional Activity. Mol. Endocrinol.
15: 2157-2171
[Abstract]
[Full Text]
-
Frasor, J., Park, K., Byers, M., Telleria, C., Kitamura, T., Yu-Lee, L.-y., Djiane, J., Park-Sarge, O.-K., Gibori, G.
(2001). Differential Roles for Signal Transducers and Activators of Transcription 5a and 5b in PRL Stimulation of ER{alpha} and ER{beta} Transcription. Mol. Endocrinol.
15: 2172-2181
[Abstract]
[Full Text]
-
Park, S.-H., Waxman, D. J.
(2001). Inhibitory Cross-talk between STAT5b and Liver Nuclear Factor HNF3beta . IMPACT ON THE REGULATION OF GROWTH HORMONE PULSE-STIMULATED, MALE-SPECIFIC LIVER CYTOCHROME P-450 GENE EXPRESSION. J. Biol. Chem.
276: 43031-43039
[Abstract]
[Full Text]
-
Davey, H. W., Xie, T., McLachlan, M. J., Wilkins, R. J., Waxman, D. J., Grattan, D. R.
(2001). STAT5b Is Required for GH-Induced Liver Igf-I Gene Expression. Endocrinology
142: 3836-3841
[Abstract]
[Full Text]
-
Grattan, D. R., Xu, J., McLachlan, M. J., Kokay, I. C., Bunn, S. J., Hovey, R. C., Davey, H. W.
(2001). Feedback Regulation of PRL Secretion Is Mediated by the Transcription Factor, Signal Transducer, and Activator of Transcription 5b. Endocrinology
142: 3935-3940
[Abstract]
[Full Text]
-
Murphy, T. L., Geissal, E. D., Farrar, J. D., Murphy, K. M.
(2000). Role of the Stat4 N Domain in Receptor Proximal Tyrosine Phosphorylation. Mol. Cell. Biol.
20: 7121-7131
[Abstract]
[Full Text]
-
Ehret, G. B., Reichenbach, P., Schindler, U., Horvath, C. M., Fritz, S., Nabholz, M., Bucher, P.
(2001). DNA Binding Specificity of Different STAT Proteins. COMPARISON OF IN VITRO SPECIFICITY WITH NATURAL TARGET SITES. J. Biol. Chem.
276: 6675-6688
[Abstract]
[Full Text]
-
Delesque-Touchard, N., Park, S.-H., Waxman, D. J.
(2000). Synergistic Action of Hepatocyte Nuclear Factors 3 and 6 on CYP2C12 Gene Expression and Suppression by Growth Hormone-activated STAT5b. PROPOSED MODEL FOR FEMALE-SPECIFIC EXPRESSION OF CYP2C12 IN ADULT RAT LIVER. J. Biol. Chem.
275: 34173-34182
[Abstract]
[Full Text]